Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:491 (25 February), doi:10.1136/bmj.332.7539.491-a
| The first 150 words of the full text of this article appear below. |
EDITORPollock et al clearly summarise the problems inherent in the UK Department of Health's new research strategy.1 2 The proposed reorganisation of primary care research networks is also a concern: pharmaceutical industry representatives may have membership of key strategic groups in reorganised primary care networks and the predominant research paradigm will become the large randomised controlled trial.
One of the clear strengths of the current networks is the broad range of studies and methods that can be identified in their research portfolios. This range of topics represents the diversity of work in primary care as well as the welcome opportunity over recent years for many to investigate an area of their practice that has fired their curiosity and enthusiasm. There are potential advantages to the NHS as a whole in practitioners becoming involved in their own research, albeit on a small scale, since this is likely to lead to
Jim Sikorski, chair
Lewisham Research Unit, London SE26 4TH j.sikorski@iop.kcl.ac.uk
Susan Robinson, research fellow, Martin Edwards, GP researcher
Lewisham Research Unit, London SE26 4TH